Coronary chronic total occlusion

C Godino1, M Carlino, R Al-Lamee

  • 1San Raffaele Scientific Institute, Milan, Italy. cosmogodino@gmail.com

Minerva Cardioangiologica
|February 11, 2010
PubMed

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) is challenging but offers benefits like reduced angina and improved survival. Advanced techniques and materials are crucial for achieving high success rates in CTO PCI.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine
  • Medical Device Technology

Background:

  • Chronic total occlusions (CTO) pose significant challenges in percutaneous coronary intervention (PCI).
  • Successful CTO recanalization improves patient outcomes, including angina relief, reduced need for bypass surgery, and enhanced long-term survival.
  • Historically, PCI success rates for CTOs were around 50%, but recent advancements have enabled higher success rates (80-90%) by some operators.

Purpose of the Study:

  • To highlight the challenges and advancements in percutaneous coronary intervention (PCI) for chronic total occlusions (CTO).
  • To emphasize the importance of skill, experience, and understanding of available materials and techniques for successful CTO PCI.
  • To underscore the need for individualized risk/benefit analysis before attempting CTO PCI.

Main Methods:

  • Review of current interventional cardiology techniques and materials for CTO PCI.
  • Analysis of factors contributing to improved success rates in CTO recanalization.
  • Discussion of clinical, imaging, and technical considerations for procedural decision-making.

Main Results:

  • Successful CTO PCI can significantly alleviate angina symptoms.
  • PCI for CTO can serve as an alternative to coronary artery bypass surgery.
  • Improved techniques and materials have led to higher success rates in CTO PCI procedures.

Conclusions:

  • Percutaneous coronary intervention for chronic total occlusions is a complex but increasingly successful procedure.
  • Achieving high success rates in CTO PCI necessitates a combination of operator expertise and advanced technological tools.
  • Careful patient selection and risk assessment are paramount for optimizing outcomes in CTO PCI.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...